SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-21-004914
Filing Date
2021-01-28
Accepted
2021-01-28 16:20:33
Documents
89
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea133557-6k_chinasxtpharma.htm 6-K 145522
2 SETTLEMENT AGREEMENT, DATED JANUARY 18, 2021, BY AND BETWEEN FT GLOBAL CAPITAL, ea133557ex4-1_chinasxt.htm EX-4.1 19093
3 FORM OF THE WARRANT ISSUED TO JIAN KE ON JANUARY 18, 2021 ea133557ex4-2_chinasxt.htm EX-4.2 175919
4 UNAUDITED INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS AS OF SEPTEMBER 30 ea133557ex99-1_chinasxt.htm EX-99.1 322519
5 GRAPHIC ex99-1_001.jpg GRAPHIC 64613
  Complete submission text file 0001213900-21-004914.txt   4135729

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE sxtc-20200930.xml EX-101.INS 619215
7 XBRL SCHEMA FILE sxtc-20200930.xsd EX-101.SCH 61898
8 XBRL CALCULATION FILE sxtc-20200930_cal.xml EX-101.CAL 64293
9 XBRL DEFINITION FILE sxtc-20200930_def.xml EX-101.DEF 168151
10 XBRL LABEL FILE sxtc-20200930_lab.xml EX-101.LAB 323564
11 XBRL PRESENTATION FILE sxtc-20200930_pre.xml EX-101.PRE 282345
Mailing Address 178 TAIDONG ROAD NORTH TAIZHOU F4 225300
Business Address 178 TAIDONG ROAD NORTH TAIZHOU F4 225300 8652386298290
China SXT Pharmaceuticals, Inc. (Filer) CIK: 0001723980 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D8 | Fiscal Year End: 0331
Type: 6-K | Act: 34 | File No.: 001-38773 | Film No.: 21565381
SIC: 2834 Pharmaceutical Preparations